Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Outcomes and Healthcare Economics of SOLTIVE Compared to Ho:YAG Laser in Urolithiasis
Sponsor: University of Kansas Medical Center
Summary
To compare intraoperative as well as postoperative outcomes of SOLTIVE Thulium laser compared to Ho:YAG laser for the treatment of urolithiasis. The hypothesis is that utilizing the SOLTIVE Thulium laser for the treatment of urolithiasis will result in a more efficient procedure, with comparable stone free rate to that of Holmium laser and subjective improvement in physician satisfaction.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2022-09-01
Completion Date
2026-03-25
Last Updated
2026-05-07
Healthy Volunteers
No
Conditions
Interventions
SOLTIVE Thulium Fiber Laser
Patients randomized to Arm A will undergo surgery to remove their kidney stone with FDA approved SOLTIVE Thulium Fiber Laser.
Ho:YAG Laser
Patients randomized to Arm B will undergo surgery to remove their kidney stone with FDA approved Ho:YAG laser.
Locations (1)
University of Kansas Medical Center
Kansas City, Kansas, United States